← All companies

CING

Cingulate Inc.

CING Nasdaq Pharmaceutical Preparations EDGAR ↗

$4.83

+0.04 +0.84%

Key statistics

from XBRL data in SEC filings

Market cap

$64.1M

Revenue (TTM)

—

Net income (TTM)

-$27.9M

EPS (TTM)

$-4.33

P/E ratio

—

Dividend yield

—

Free cash flow

-$17.4M

Cash

$25.9M

Total assets

$30.9M

Gross margin

—

52-week range

$3.16 – $11.89

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 23, 2026 8-K Director or officer change; Shareholder vote results Jul 14, 2026 8-K Director or officer change; Regulation FD disclosure Jul 2, 2026 8-K Regulation FD disclosure Jun 16, 2026 8-K Regulation FD disclosure; Other events Jun 2, 2026 8-K Director or officer change May 19, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Director or officer change Apr 2, 2026 8-K Entered a material agreement; Shareholder vote results Mar 24, 2026 10-K Fiscal year ended 2025-12-31 Mar 18, 2026 8-K Results of operations (earnings release); Other events Mar 18, 2026 8-K Unregistered sale of equity; Director or officer change; Regulation FD disclosure; Other events Feb 17, 2026 8-K Unregistered sale of equity; Other events Feb 6, 2026 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws Jan 28, 2026 8-K Other events Jan 15, 2026 8-K Unregistered sale of equity Jan 2, 2026 8-K Director or officer change Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Nov 10, 2025 8-K Regulation FD disclosure; Other events Oct 14, 2025 8-K Shareholder vote results Sep 25, 2025 8-K Unregistered sale of equity Sep 5, 2025 8-K Director or officer change Aug 28, 2025 10-Q Quarter ended 2025-06-30 Aug 19, 2025 8-K Results of operations (earnings release) Aug 19, 2025 8-K Director or officer change Aug 15, 2025 8-K Director or officer change Aug 8, 2025 8-K Regulation FD disclosure; Other events Aug 6, 2025 8-K Unregistered sale of equity Jul 25, 2025 8-K Entered a material agreement; Unregistered sale of equity Jul 22, 2025 8-K Director or officer change; Shareholder vote results Jun 11, 2025 8-K Terminated a material agreement May 13, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Entered a material agreement; Regulation FD disclosure Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 26, 2025 8-K Regulation FD disclosure; Other events Mar 4, 2025